The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.

[1]  M. Pike,et al.  The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. , 1988, British Journal of Cancer.

[2]  M. Coleman,et al.  Long‐term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy , 1987 .

[3]  W. Willett,et al.  A PROSPECTIVE COHORT STUDY OF POSTMENOPAUSAL HORMONE USE AND RISK OF BREAST CANCER IN US WOMEN , 1987 .

[4]  B. Henderson,et al.  The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for breast cancer prevention. , 1987, British Journal of Cancer.

[5]  D. Wysowski,et al.  Sex hormone levels in serum in relation to the development of breast cancer. , 1987, American journal of epidemiology.

[6]  D. Rose,et al.  Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins. , 1987, Journal of the National Cancer Institute.

[7]  D. Collins,et al.  Long-term effect of a first pregnancy on the secretion of prolactin. , 1987, The New England journal of medicine.

[8]  G. Buehring,et al.  Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth , 1987, Cancer.

[9]  P. Wingo,et al.  The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. , 1987, JAMA.

[10]  J. Boreham,et al.  Serum retinol and subsequent risk of cancer. , 1986, British Journal of Cancer.

[11]  G. Clark,et al.  Binding of oestradiol to blood proteins and aetiology of breast cancer , 1986, International journal of cancer.

[12]  R. Hoover,et al.  Menopausal oestrogens and breast cancer risk: an expanded case-control study. , 1986, British Journal of Cancer.

[13]  K. McPherson,et al.  The pill and breast cancer: why the uncertainty? , 1986, British medical journal.

[14]  A. Morrison,et al.  Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. , 1986, Journal of the National Cancer Institute.

[15]  W. Frontera,et al.  Bone mineral content and levels of gonadotropins and estrogens in amenorrheic running women. , 1986, The Journal of clinical endocrinology and metabolism.

[16]  T. Longacre,et al.  A Correlative Morphologic Study of Human Breast and Endometrium in the Menstrual Cycle , 1986, The American journal of surgical pathology.

[17]  D. Ota,et al.  Obesity, non‐protein‐bound estradiol levels, and distribution of estradiol in the sera of breast cancer patients , 1986, Cancer.

[18]  L. Kolonel,et al.  The association of replacement estrogens with breast cancer , 1986, International journal of cancer.

[19]  J. Witschi,et al.  Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to non-athletes. , 1985, British Journal of Cancer.

[20]  W. Willett,et al.  Relative weight and risk of breast cancer among premenopausal women. , 1985, American journal of epidemiology.

[21]  D. Anderson,et al.  Serum steroid binding proteins and the bioavailability of estradiol in relation to breast diseases. , 1985, Journal of the National Cancer Institute.

[22]  B. Modan,et al.  Overweight and changes in weight throughout adult life in breast cancer etiology. A case-control study. , 1985, American journal of epidemiology.

[23]  F. Kasumi,et al.  Plasma testosterone and breast cancer. , 1985, European journal of cancer & clinical oncology.

[24]  M. Pike,et al.  Do regular ovulatory cycles increase breast cancer risk? , 1985, Cancer.

[25]  J. Vaitukaitis,et al.  Hormonal changes associated with changes in body weight. , 1985, Clinical obstetrics and gynecology.

[26]  M. Ghilchik,et al.  The distribution of oestradiol in plasma from postmenopausal women with or without breast cancer: Relationships with metabolic clearance rates of oestradiol , 1985, International journal of cancer.

[27]  C. Grubbs,et al.  Chemoprevention of N-Nitroso-N-methylurea-Induced Mammary Cancers by Pretreatment with 17β-Estradiol and Progesterone , 1985 .

[28]  C. la Vecchia,et al.  Menstrual cycle patterns and the risk of breast disease. , 1985, European journal of cancer & clinical oncology.

[29]  A. Hart,et al.  Non-protein bound oestradiol, sex hormone binding globulin, breast cancer and breast cancer risk. , 1985, British Journal of Cancer.

[30]  C. Welsch,et al.  The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice , 1984, Cancer.

[31]  R. Hiatt,et al.  Exogenous estrogen and breast cancer after bilateral oophorectomy , 1984, Cancer.

[32]  G. Secreto,et al.  High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast. , 1984, Cancer research.

[33]  A. Rimm,et al.  The association of girth measurements with disease in 32,856 women. , 1984, American journal of epidemiology.

[34]  M. Pike,et al.  Age at natural menopause and breast cancer risk: the effect of errors in recall. , 1984, American journal of epidemiology.

[35]  Gambrell Rd,et al.  Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. , 1983 .

[36]  M. Reed,et al.  Plasma levels of estrone, estrone sulfate, and estradiol and the percentage of unbound estradiol in postmenopausal women with and without breast disease. , 1983, Cancer research.

[37]  D. Apter,et al.  Early menarche, a risk factor for breast cancer, indicates early onset of ovulatory cycles. , 1983, The Journal of clinical endocrinology and metabolism.

[38]  D. G. Hoel,et al.  ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer , 1983, Nature.

[39]  J. Shelton,et al.  Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections. , 1983, Journal of the American Medical Association (JAMA).

[40]  M. Pike,et al.  The epidemiology of endometrial cancer in young women. , 1983, British Journal of Cancer.

[41]  J. Annegers,et al.  Chronic Anovulation Syndrome and Associated Neoplasia , 1983, Obstetrics and gynecology.

[42]  B. Macmahon,et al.  Urine estrogens, frequency of ovulation, and breast cancer risk: case-control study in premenopausal women. , 1983, Journal of the National Cancer Institute.

[43]  G. Secreto,et al.  Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients. , 1983, British Journal of Cancer.

[44]  G. Secreto,et al.  Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast. , 1983, European journal of cancer & clinical oncology.

[45]  D. Moore,et al.  Breast carcinoma etiological factors. , 1983, Advances in cancer research.

[46]  H. Olsson,et al.  Retrospective assessment of menstrual cycle length in patients with breast cancer, in patients with benign breast disease, and in women without breast disease. , 1983, Journal of the National Cancer Institute.

[47]  D. Janerich,et al.  Evidence for a crossover in breast cancer risk factors. , 1982, American journal of epidemiology.

[48]  B. Macmahon,et al.  Age at menarche, urine estrogens and breast cancer risk , 1982, International journal of cancer.

[49]  G. Raab,et al.  Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality. , 1982, British Journal of Cancer.

[50]  B. Zumoff.  Relationship of obesity to blood estrogens. , 1982, Cancer research.

[51]  R. Wallace,et al.  Cyclic ovarian function and breast cancer. , 1982, Cancer research.

[52]  G. Schneider,et al.  Obesity, androgens, estrogens, and cancer risk. , 1982, Cancer research.

[53]  M. Pike,et al.  Endogenous hormones as a major factor in human cancer. , 1982, Cancer research.

[54]  B. Hulka,et al.  Breast cancer and estrogen replacement therapy. , 1982, American journal of obstetrics and gynecology.

[55]  G. Clark,et al.  Serum concentrations of total and non‐protein‐bound oestradiol in patients with breast cancer and in normal controls , 1982, International journal of cancer.

[56]  P. Siiteri,et al.  Estrogens and Breast Cancer , 1986, Clinical obstetrics and gynecology.

[57]  J. Witschi,et al.  Delayed menarche and amenorrhea of college athletes in relation to age of onset of training. , 1981, JAMA.

[58]  R. Hoover,et al.  Conjugated estrogens and breast cancer risk in women. , 1981, Journal of the National Cancer Institute.

[59]  J. Tonascia,et al.  Breast cancer incidence in women with a history of progesterone deficiency. , 1981, American journal of epidemiology.

[60]  J. Kelsey,et al.  Exogenous estrogens and other factors in the epidemiology of breast cancer. , 1981, Journal of the National Cancer Institute.

[61]  T. Anderson,et al.  Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. , 1981, British Journal of Cancer.

[62]  F. Vogel,et al.  The correlation of histologic changes in the human breast with the menstrual cycle. , 1981, The American journal of pathology.

[63]  R. Wallace,et al.  Relationship of body weight to menarcheal and menopausal age: implications for breast cancer risk. , 1981, The Journal of clinical endocrinology and metabolism.

[64]  K. Rothman,et al.  Oral Contraceptives and Breast Cancer , 1980 .

[65]  D. English,et al.  Oestrogens and endometrial cancer: effect of other risk factors on the association. , 1980, Maturitas.

[66]  A. Schindler,et al.  Plasma hormones in pre- and postmenopausal breast cancer. , 1980, Journal of steroid biochemistry.

[67]  H. Ory,et al.  The association of depo-medroxyprogesterone acetate and breast cancer. , 1980, Contraception.

[68]  B. Henderson,et al.  A case-control study of menopausal estrogen therapy and breast cancer. , 1980, JAMA.

[69]  T. Nemoto,et al.  Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer. , 1979, Journal of the National Cancer Institute.

[70]  A. Ferenczy,et al.  Proliferation kinetics of human endometrium during the normal menstrual cycle. , 1979, American journal of obstetrics and gynecology.

[71]  R. Wallace,et al.  HORMONAL REGULATION OF THE MENSTRUAL CYCLE IN WOMEN WITH BREAST CANCER: EFFECT OF ADJUVANT CHEMOTHERAPY , 1979, Clinical endocrinology.

[72]  J. Kelsey.  A review of the epidemiology of human breast cancer. , 1979, Epidemiologic reviews.

[73]  J. Vegelius,et al.  Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. , 1979, Upsala journal of medical sciences.

[74]  L. Garfinkel,et al.  Variations in mortality by weight among 750,000 men and women. , 1979, Journal of chronic diseases.

[75]  A. Treloar,et al.  Menstrual cycle patterns and breast cancer risk factors. , 1978, Cancer research.

[76]  C. Longcope,et al.  Relationship between urine and plasma estrogen ratios. , 1978, Cancer research.

[77]  P. Siiteri.  Steroid hormones and endometrial cancer. , 1978, Cancer research.

[78]  B. Macmahon,et al.  Estrogen profiles of premenopausal women with breast cancer. , 1978, Cancer research.

[79]  W. Malarkey,et al.  Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. , 1977, Cancer research.

[80]  D. Mishell,et al.  Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel. , 1977, American journal of obstetrics and gynecology.

[81]  M. Yoshida,et al.  Hormonal status of breast cancer. III. Further analysis of ovarian-adrenal dysfunction. , 1977, Journal of the National Cancer Institute.

[82]  R. F. Vollman.  The menstrual cycle. , 1977, Major problems in obstetrics and gynecology.

[83]  J. Masters,et al.  Cyclic Variation of DNA synthesis in human breast epithelium. , 1977, Journal of the National Cancer Institute.

[84]  J. Meyer.  Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones. , 1977, Human pathology.

[85]  B. Macmahon,et al.  Menopausal estrogens and breast cancer. , 1976, The New England journal of medicine.

[86]  R. Prescott,et al.  CIRCULATING HORMONE CONCENTRATIONS IN WOMEN WITH BREAST CANCER , 1976, The Lancet.

[87]  J. Thijssen,et al.  Androgens in postmenopausal breast cancer: excretion, production and interaction with estrogens. , 1975, Journal of steroid biochemistry.

[88]  G. Secreto,et al.  Androgens in breast cancer , 1975 .

[89]  R. Sellwood,et al.  Serum Oestradiol-17β in Women with Benign and Malignant Breast Disease , 1974, British Journal of Cancer.

[90]  F. D. Waard,et al.  A prospective study in general practice on breast‐cancer risk in postmenopausal women , 1974, International journal of cancer.

[91]  J. Hayward,et al.  OVULATORY FAILURE IN A NORMAL POPULATION AND IN PATIENTS WITH BREAST CANCER , 1974, The Journal of obstetrics and gynaecology of the British Commonwealth.

[92]  S. Korenman,et al.  Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase. , 1974, The Journal of clinical endocrinology and metabolism.

[93]  G. Secreto,et al.  Androgens in breast cancer. II. Endometrial adenocarcinoma and breast cancer in married postmenopausal women. , 1974, American journal of obstetrics and gynecology.

[94]  O. Blanchard,et al.  Endocrine profiles and breast cancer. , 1973, Lancet.

[95]  B. Macmahon,et al.  Menopause and breast cancer risk. , 1972, Journal of the National Cancer Institute.

[96]  M. Grönroos,et al.  Estrogen metabolism in postmenopausal women with primary and recurrent breast cancer. , 1968, European journal of cancer.

[97]  C. Hopkins,et al.  II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE. , 1965, American journal of obstetrics and gynecology.

[98]  C. Hopkins,et al.  I. URINARY EXCRETION OF NEUTRAL 17-KETOSTEROIDS AND PREGNANDEIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE. , 1965, American journal of obstetrics and gynecology.

[99]  L. Risholm,et al.  OOPHORECTOMY AND CORTISONE TREATMENT AS A METHOD OF ELIMINATING OESTROGEN PRODUCTION IN PATIENTS WITH BREAST CANCER. , 1964, Acta endocrinologica.

[100]  R. Grattarola.  The premenstrual endometrial pattern of women with breast cancer. A study of progestational activity , 1964, Cancer.

[101]  G. Mitchell,et al.  The relation of obesity to menstrual disturbances. , 1952, The New England journal of medicine.

[102]  N. F. Miller.  Nausea and vomiting in pregnancy , 1922 .